Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Ossium Health, Inc.
M.D. Anderson Cancer Center
University of Miami
Thomas Jefferson University
Case Comprehensive Cancer Center
Instituto Nacional de Cancer, Brazil
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
University of Liege